Is NLTX or NOBL a better dividend investment in 2026?

NLTX currently yields 57.31% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: NLTX offers higher current income.

What is the dividend yield difference between NLTX and NOBL?

NLTX has a forward dividend yield of 57.31% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 53.31 percentage points.

Home › Compare › NLTX vs NOBL

NLTX vs NOBL: Dividend Comparison 2026

NLTX yields 57.31% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NLTX wins by $542.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NLTX

● Live price

57.31%

Share price

$3.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$570.4K

Annual income

$128,685.50

Full NLTX calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — NLTX vs NOBL

📍 NLTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NLTX	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NLTX + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NLTX pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NLTX

Annual income on $10K today (after 15% tax)

$4,871.06/yr

After 10yr DRIP, annual income (after tax)

$109,382.68/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, NLTX beats the other by $108,618.36/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NLTX + NOBL for your $10,000?

NLTX: 50%NOBL: 50%

100% NOBL50/50100% NLTX

Portfolio after 10yr

$299.2K

Annual income

$64,792.35/yr

Blended yield

21.65%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NLTX right now

NLTX

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Altman Z

-1.6

Piotroski

3/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NLTX buys

NOBL buys

No recent congressional trades found for NLTX or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNLTXNOBL

Forward yield	57.31% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$570.4K ✓	$28.0K
Annual income after 10y	$128,685.50 ✓	$899.19
Total dividends collected	$468.8K ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NLTX vs NOBL ($10,000, DRIP)

Year	NLTX Portfolio	NLTX Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$16,431	$5,730.66	$11,120	$420.00	+$5.3K → NLTX
2	$26,381	$8,799.86	$12,357	$458.31	+$14.0K → NLTX
3	$41,432	$13,204.52	$13,721	$499.76	+$27.7K → NLTX
4	$63,714	$19,381.50	$15,227	$544.58	+$48.5K → NLTX
5	$96,028	$27,854.89	$16,885	$593.02	+$79.1K → NLTX
6	$141,986	$39,236.06	$18,713	$645.34	+$123.3K → NLTX
7	$206,144	$54,218.66	$20,724	$701.81	+$185.4K → NLTX
8	$294,142	$73,568.04	$22,938	$762.73	+$271.2K → NLTX
9	$412,837	$98,105.15	$25,372	$828.41	+$387.5K → NLTX
10	$570,422	$128,685.50	$28,047	$899.19	+$542.4K → NLTX

NLTX vs NOBL: Complete Analysis 2026

NLTX — Stock

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Full NLTX Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this NLTX vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NLTX vs SCHD NLTX vs JEPI NLTX vs O NLTX vs KO NLTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.